NorthLinks Bio
PrivateLast Round
Series A
Jun 23, 2026
Total Funding Raised
$34M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NorthLinks Bio is a biotechnology company developing broad-spectrum antiviral preventative medicines for respiratory viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorthLinks Bio Comparables
Compare NorthLinks Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leyden Labs | 81% | |
| Pulmotect | 79% | |
| RQ Biotechnology Limited | 74% |
NorthLinks Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 23, 2026 |
NorthLinks Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
$34M raised, led by RA Capital Management.
Recent news
Latest coverage and updates
- receives_financingJun 23, 2026
NorthLinks Bio received financing of $34M in financing on Jun 1st '26.
- is_developingJun 23, 2026
NorthLinks Bio is developing "HEX17," a convenient self-administered intranasal spray on Jun 23rd '26.
NorthLinks Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NorthLinks Bio's valuation, stock price, and market status.
Is NorthLinks Bio a public or private company?
NorthLinks Bio is a private company.
What is the current stock price of NorthLinks Bio?
NorthLinks Bio is a private company with no public stock price. No recent secondary market data is available.
How much is NorthLinks Bio worth (valuation)?
Valuation information for NorthLinks Bio is not publicly available.
Can I buy NorthLinks Bio stock?
NorthLinks Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NorthLinks Bio's last funding round?
NorthLinks Bio's most recent funding round was Series A on June 23, 2026.
Who are the main investors in NorthLinks Bio?
Key investors in NorthLinks Bio include RA Capital Management.
Will NorthLinks Bio IPO soon?
No public IPO plans have been announced for NorthLinks Bio.
How can I track NorthLinks Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NorthLinks Bio's secondary market activity and sign up for updates.